OOIR: Observatory of International Research

Papers

(The median citation count of International Clinical Psychopharmacology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?	42
The role of personality traits in following quarantine orders during the COVID-19 pandemic	35
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia	20
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?	19
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder	18
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge	17
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure	16
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?	15
Antidepressant psychopharmacology: is inflammation a future target?	14
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial	14
Clinical specificity profile for novel rapid acting antidepressant drugs	13
Open issues in bipolar and antipsychotic treatments	12
Managing depression in the elderly: real-world clinical considerations and perspectives	12
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case	12
Debated issues in major psychoses	11
Case series on aripiprazole and dopamine supersensitivity psychosis	11
Dropped-Head syndrome: a possible new variant of clozapine-induced inflammation during titration	11
Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition	11
Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder	10
Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trials	10
Suicide in prison in the North of Italy (1993–2022): a case-control study examining differences between suicides inside and outside prison	10
Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report	10
Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorder	10
Prevalence and correlates of prescription drug abuse and misuse among adult prisoners: a systematic review	10
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors	10

Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia	10
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?	10
The Gordian knot of the immune-redox systems’ interactions in psychosis	10
Modulating factors in mood disorders treatment	9
Differentiating aspects of oral and long-acting injectable antipsychotic drugs for tailoring the therapy of schizophrenia in clinical practice: a narrative review	9
Elevated liver transaminases among patients with psychiatric disorders	9
Suicide behind bars: time to tackle barriers to mental healthcare access in prisons	9
Immediate-release vs. prolonged-release lithium formulations in bipolar disorder: a 2-year comparative study	8
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series	8
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia	8
Navigating the pharmacologic complexities of QTc prolongation: assessing the cumulative burden in individuals with serious mental illness	8
Vitamin E in the treatment of tardive dyskinesia: a meta-analysis	8
Allergic reaction induced by subcutaneous administration of ketamine: a case report	8
Innovation in psychopharmacology	8
The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results	8
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features	8
Advances in the treatment of depression	7
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies	7
Manic episode in a patient with pancreatic adenocarcinoma: a case report	7
Case report and systematic review of cerebellar vermis alterations in psychosis	7
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study	7
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects	7
Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report	6
The challenge of managing difficult to treat psychiatric conditions	6
The relationship between mobile phone addiction and depression, anxiety, and sleep quality in medical students	6
Increased risk of death compared to other antipsychotics in elderly clozapine users in Poland	6
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study	6
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?	6
Persian translation and validation of community attitudes toward the mentally ill scale: a tool for assessing social stigma about mental illness	6
Interplay of environmental and clinical factors in psychiatric disorders	6
Capillary blood sampling for the determination of clozapine concentrations: analytical validation and patient experience	6
Differentiating the third generation of antipsychotics: a focus on lumateperone’s similarities and differences	6
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial	6
Acceptability of transdermal antipsychotic patches by patients who refuse oral medication and their effectiveness in preventing recurrence of delirium: a retrospective observational study	5
Diabetes mellitus in patients with chronic bipolar disorder: prevalence, clinical correlates and relationship with homocysteine	5
The potential use of daridorexant in eating disorders: beyond the treatment of insomnia?	5
The effect of crocin versus sertraline in treatment of mild to moderate postpartum depression: a double-blind, randomized clinical trial	5
Efficacy and safety of adjunctive therapy with lumateperone in major depressive disorder: a randomized-, double-blind, placebo-controlled clinical trial	5
Frequency, risk factors, and impacts on quality of life of the restless legs syndrome and side effects among antidepressant users in a tertiary hospital: an observational cross-sectional study	5
Lurasidone in first-episode psychosis with predominant depressive symptoms: a case report	5
The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence	5
Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation	5
Impact of long-acting injectable aripiprazole on the concomitant medication and antipsychotic polypharmacy: a retrospective, observational study of 127 patients with psychosis	5
An investigation into the association between suicide mortality rate and lithium levels in potable water: a review study	5
Does tramadol dependence impair cognitive functions?	5
Evaluating the influence of nonproblematic alcohol intake on the outcome of major depression	5
Aripiprazole: examining the clinical implications of D2 affinity	5
Pharmacological and philosophical considerations for the around-the-clock use of scheduled melatonin to promote sedation and reduce aggression in individuals with serious mental illness: a case report	5
Intravenous trazodone for the treatment of psychomotor agitation and associated symptoms in major depressive disorder patients experiencing a depressive episode with mixed features	5
In search of clinical targets for suicide prevention in major depressive disorder	5

Psychometric validation of the Persian version of the Mental Health Knowledge Schedule	5
An algorithmic approach to the case management of patients diagnosed with schizophrenia and substance use disorders: what is the evidence?	5
Associations of adolescent psychosocial factors to later benzodiazepine use: a population-based follow-up study of adolescent psychiatric inpatients in Northern Finland	4
Agranulocytosis after long-term clozapine use: a case report	4
The effect of early or late initiation of long-acting antipsychotics on the caregiver burden in schizophrenia	4
Treatment adherence rates across different psychiatric disorders and settings: findings from a large patient cohort	4
Severe methodological problems in a recent review and analysis of the association between lithium concentration in potable water and suicide rates	4
Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder	4
Sex-controlled differences in sertraline and citalopram efficacies in major depressive disorder: a randomized, double-blind trial	4
Crocus sativus (saffron) adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled trial	4
Successful clozapine rechallenge after myopericarditis: a case report	4
Short-term, but not long-term, beneficial effects of concomitant benzodiazepine use on clinical course in patients with schizophrenia	4
Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder	4
Catatonic postpartum paternal depression as a first debut of a bipolar disorder: a case report	4
Brexpiprazole augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary retrospective observational study	4
Spanish versions and validation of a series of rating scales and visual analogue scales to assess the subjective effects of cannabis	4
Comparing adherence and persistence of common selective serotonin reuptake inhibitors in veterans with major depressive disorder: a retrospective analysis of Veterans Affairs healthcare data	4
Clinical correlates and prognostic impact of binge-eating symptoms in major depressive disorder	3
Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis	3
Dissociative episode and panic attacks triggered by pitolisant in a narcoleptic patient	3
Psychopharmacology: past, present and future	3
Antidepressant treatment in complex clinical pictures	3
Risperidone as an adjuvant treatment for obsessive-compulsive symptoms in patients with bipolar disorder: a randomized, double-blind, placebo-controlled clinical trial	3
DRESS syndrome: quetiapine associated case report and literature review	3
Lurasidone as add-on to fluoxetine in obsessive-compulsive disorder with comorbid restrictive anorexia: a case report	3
Antidepressants use in Italy: an ecological study of national and regional trends and associated factors	3
Assessment of clinical outcomes in patients with inflammatory arthritis: analysis from the UK Medical Cannabis Registry	3
Occurrence of involuntary movements after prolonged misuse of zolpidem: a case report	3
Unleashing the power of pooled and subgroup analyses in psychiatry	3
More must be done to reduce cardiovascular risk for patients on antipsychotic medications	3
Can bupropion treat COVID-19–induced brain fog? A case series	3
Phosphodiesterase inhibitor and selective serotonin reuptake inhibitor combination therapy versus monotherapy for the treatment of major depressive disorder: a systematic review and meta-analysis	3
Rhabdomyolysis during adjunctive treatment with cariprazine in a clozapine-resistant schizophrenia patient	3
Oxcarbazepine versus sodium valproate in treatment of acute mania: a double-blind randomized clinical trial	3
Safety and efficacy of daridorexant in the treatment of insomnia: a systematic review and meta-analysis of randomized controlled trials	3
Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol	3
Remission of functional motor symptoms following esketamine administration in a patient with treatment-resistant depression: a single-case report	3
Investigating the psychological effects of home quarantine during the early peaks of the COVID-19 pandemic: a survey from Iran	3
Antidepressant drug use and regional prescribing patterns in Germany: results from a large population-based study	3
Characteristics and outcomes of cases with methylphenidate abuse, dependence or withdrawal: an analysis of spontaneous reports in EudraVigilance	3
Clinical experiences with intranasal esketamine for major depressive disorder resistant to treatment and with a psychiatric emergency: case presentations	3
Resistance to antidepressant treatment among patients with major depressive disorder: a nationwide study	3
Medicare claims analysis of agents used to manage dementia-related psychosis: a treatment pattern study	3
Can levetiracetam improve clinical symptoms in schizophrenic patients? A randomized placebo-controlled clinical trial	3
Type 2 diabetes mellitus is associated with manic morbidity in elderly patients with mood disorders	3
Pharmacologic treatment of depression in Alzheimer’s disease	3
Raising awareness for adult ADHD diagnosis: addressing diagnostic challenges, comorbidities, and the path to proper recognition	3